BIOS Capital Management, LP Q2 2025 Filing

Filed August 12, 2025

Portfolio Value

$72.6B

Holdings

6

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACTUACTUATE THERAPEUTICS INC
9,965,079$60.9B83.89%
2
IRDOPUS GENETICS INC
3,683,429$3.5B4.77%
3
LTRNLANTERN PHARMA INC
1,075,952$3.4B4.68%
4
RNTXREIN THERAPEUTICS INC
1,690,751$2.4B3.26%
5
CGTXCOGNITION THERAPEUTICS INC
6,000,000$1.9B2.56%
6
INABEURIN8BIO INC
286,664$599.1M0.83%